(lp0
S'Clovis Oncology Announces Data Presentations at AACR Annual Meeting 2017 Business Wire  - 10 hours ago BOULDER, Colo.----Clovis Oncology, Inc.  today announced that rucaparib preclinical data will be presented at the American Association for Cancer Research  Annual Meeting 2017.Clovis Oncology Inc  Given a $77.00 Price Target at Piper Jaffray Companies - The Cerbat Gem'
p1
aS'Clovis Looks Vastly Overpriced Seeking Alpha - Mar 27, 2017 Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti-cancer agents.'
p2
aS'Form 4 Clovis Oncology, Inc. For: Mar 27 Filed by: MAHAFFY PATRICK J StreetInsider.com - 8 hours ago Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1. 1. Name and Address of Reporting Person *. MAHAFFY PATRICK J. , , . C/O CLOVIS ONCOLOGY, INC. 5500 FLATIRON&nbsp;...'
p3
aS'Clovis Oncology Stock-Drop Claims Still Fall Short, Court Told Law360  - Mar 20, 2017 Law360, New York  -- Three underwriters accused of helping Clovis Oncology Inc. defraud investors in a stock offering asked a Colorado federal court Friday to dismiss claims against them, saying changes that were supposed&nbsp;...'
p4
aS"Apple, Netflix, Clovis Oncology Upgraded Schaeffers Research  - Mar 15, 2017 Analysts are weighing in on iPhone maker Apple Inc. , &quot;FANG&quot; stock Netflix, Inc. , and cancer treatment specialist Clovis Oncology Inc . Here's a quick roundup of today's bullish brokerage notes on AAPL,&nbsp;...Clovis Oncology Inc.  Moves Higher on Volume Spike for March 15 - Equities.comAnalyst Activity  Chardan Capital Reiterates Sell on Clovis Oncology (NASDAQ ... - Market Exclusive"
p5
aS'Clovis Oncology Inc Risk Points versus Health Care CML News - Mar 8, 2017 This is a scatter plot analysis of the critical risk points from the option market for Clovis Oncology Inc  compared to its own past and the Health Care ETF.Traders Secrets on Telephone and Data Systems, Inc. , Clovis Oncology ... - StockNewsJournalCompany Performance of Clovis Oncology, Inc.  Increases 7.37% - Times Money'
p6
aS'Clovis Oncology, Inc.  Technical Analysis: Support and Resistance on ... USA Commerce Daily - 17 hours ago With all other things going on, Clovis Oncology, Inc.  has been on a run - rising 51.7 percent in just three months.'
p7
aS'Insider Trading Activity Clovis Oncology Inc   Insider Sold 3000 ... Market Exclusive - Mar 16, 2017 On 8/16/2012 Edward J Mckinley, Director, bought 9,701 with an average share price of $15.50 per share and the total transaction amounting to $150,365.50.'
p8
aS"Option Market Alert: Clovis Oncology Inc Implied Price Swing Hits An Unsually ... CML News - Mar 19, 2017 Risk Alert: Before we dive into any analysis we simply note that Clovis Oncology Inc  risk is elevated. We'll detail it below -- but that's the lede -- the option market is starting to flash those neon lights that signal &quot;risk is rising ...Featured Stock for Investors: Clovis Oncology, Inc.  - HugoPressClovis Oncology Inc  Earns Hold Rating from JPMorgan Chase &amp; Co. - Chaffey Breeze"
p9
aS"Clovis Oncology Presents New Data from Phase 2 Studies of Rucaparib in ... Yahoo Finance - Mar 12, 2017 Clovis Oncology, Inc.  announced new data from parts 1 and 2 of the ongoing ARIEL2 Phase 2 study being presented today at the 2017 Society of Gynecologic Oncology  Annual Meeting on Women's Cancer in National Harbor, MD."
p10
a.